Taysha Gene Therapies Inc... (TSHA)
NASDAQ: TSHA
· Real-Time Price · USD
2.92
-0.02 (-0.68%)
At close: Aug 15, 2025, 3:59 PM
2.98
1.88%
After-hours: Aug 15, 2025, 07:17 PM EDT
Taysha Gene Therapies Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.99M | 2.3M | 2.02M | 1.79M | 1.11M | 3.41M | 3.6M | 4.75M | 2.4M | 4.71M | 2.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 277K | n/a | n/a | n/a | n/a | 325K | 366K | 331K | 703K | 631K | 1.68M | 300K | 300K | 257K | 209K | 166K | 85K | 32K |
Gross Profit | 1.71M | 2.3M | 2.02M | 1.79M | 1.11M | 3.41M | 3.24M | 4.42M | 1.69M | 4.08M | 823K | -300K | -300K | -257K | -209K | -166K | -85K | -32K |
Operating Income | -26.75M | -21.42M | -19.93M | -25.9M | -21.3M | -24.33M | -16.25M | -16.25M | -23.38M | -16.56M | -55.12M | -25.07M | -32.98M | -49.27M | -49.72M | -50.68M | -40.77M | -32.09M |
Interest Income | 1.86M | 1.33M | 1.7M | 2.11M | 1.44M | 1.69M | 1.92M | 1.11M | 223K | 319K | 199K | 9K | 27K | 14K | 29K | 37K | 40K | 66K |
Pretax Income | -26.88M | -21.53M | -18.79M | -25.52M | -20.93M | -24.06M | 47.74M | -117.09M | -24.6M | -17.62M | -55.72M | -26.31M | -33.87M | -50.11M | -50.39M | -51.19M | -40.93M | -32.02M |
Net Income | -26.88M | -21.53M | -18.79M | -25.52M | -20.93M | -24.06M | 47.74M | -117.09M | -24.6M | -20.06M | -58.06M | -27.54M | -34.76M | -50.95M | -50.39M | -51.19M | -40.93M | -32.02M |
Selling & General & Admin | 8.6M | 8.16M | 6.63M | 7.9M | 7.34M | 7.08M | 6.72M | 8.59M | 5.99M | 8.75M | 7.34M | 8.68M | 9.87M | 11.47M | 11.81M | 11.15M | 10.13M | 8.24M |
Research & Development | 20.14M | 15.56M | 15.32M | 14.95M | 15.07M | 20.66M | 12.68M | 11.79M | 19.79M | 12.51M | 13.86M | 16.39M | 23.12M | 37.8M | 37.92M | 39.53M | 30.64M | 23.85M |
Other Expenses | n/a | n/a | n/a | 4.84M | n/a | n/a | 449K | 616K | 3K | -8K | -6K | -1K | -3K | -8K | n/a | n/a | n/a | n/a |
Operating Expenses | 28.74M | 23.72M | 21.95M | 27.69M | 22.41M | 27.74M | 19.85M | 21M | 25.78M | 21.27M | 21.2M | 25.07M | 32.98M | 49.27M | 49.72M | 50.68M | 40.77M | 32.09M |
Interest Expense | 17K | 19K | 22K | 24K | 27K | 29K | 713K | 1.47M | 1.44M | 1.37M | 796K | 1.08M | 743K | 672K | 691K | 543K | 194K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 28.74M | 23.72M | 21.95M | 27.69M | 22.41M | 27.74M | 19.85M | 21M | 25.78M | 21.27M | 21.2M | 25.07M | 32.98M | 49.27M | 49.72M | 50.68M | 40.77M | 32.09M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.44M | 2.33M | 1.23M | 888K | 843K | n/a | 37K | 40K | 66K |
Shares Outstanding (Basic) | 297.99M | 269.31M | 250.13M | 267.82M | 232.82M | 231.25M | 186.96M | 251.4M | 256.98M | 253.04M | 225.54M | 163.75M | 160.57M | 152.7M | 152.44M | 152.02M | 149.92M | 147.97M |
Shares Outstanding (Diluted) | 297.99M | 269.31M | 250.13M | 267.82M | 232.82M | 231.25M | 186.96M | 251.4M | 256.98M | 253.04M | 225.54M | 163.75M | 160.57M | 152.7M | 152.44M | 152.02M | 149.92M | 147.97M |
EPS (Basic) | -0.09 | -0.08 | -0.07 | -0.1 | -0.09 | -0.1 | 0.26 | -0.52 | -0.38 | -0.32 | -1.03 | -0.67 | -0.87 | -1.33 | -1.32 | -1.35 | -1.09 | -0.87 |
EPS (Diluted) | -0.09 | -0.08 | -0.07 | -0.1 | -0.09 | -0.1 | 0.26 | -0.52 | -0.38 | -0.32 | -1.03 | -0.67 | -0.87 | -1.33 | -1.32 | -1.35 | -1.09 | -0.87 |
EBITDA | -26.75M | -21.23M | -18.46M | -25.21M | -20.58M | -23.71M | 48.82M | -115.28M | -22.45M | -15.62M | -53.25M | -25.18M | -32.98M | -49.39M | -49.49M | -50.48M | -40.65M | -31.99M |
EBIT | -26.86M | -21.51M | -18.76M | -25.5M | -20.9M | -24.03M | 48.45M | -115.62M | -23.16M | -16.25M | -54.93M | -25.07M | -32.96M | -49.26M | -49.7M | -50.64M | -40.73M | -32.02M |
Depreciation & Amortization | 277K | 283K | 304K | 294K | 322K | 325K | 366K | 331K | 703K | 631K | 1.68M | 300K | 300K | 257K | 209K | 166K | 85K | 32K |